SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-029297
Filing Date
2021-11-19
Accepted
2021-11-19 09:16:29
Documents
1
Period of Report
2021-11-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3145
  Complete submission text file 0001493152-21-029297.txt   4580
Mailing Address 740 BROADWAY 9TH FLOOR NEW YORK NY 10003
Business Address
Meckler Jeffrey A (Reporting) CIK: 0001506916 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40652 | Film No.: 211426564

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations